BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/16/2017 10:39:00 AM | Browse: 880 | Download: 1383
Publication Name World Journal of Hepatology
Manuscript ID 28132
Country/Territory United States
Received
2016-06-27 11:59
Peer-Review Started
2016-06-27 14:21
To Make the First Decision
2016-08-26 08:16
Return for Revision
2016-08-29 17:03
Revised
2016-09-23 21:01
Second Decision
2016-11-22 17:40
Accepted by Journal Editor-in-Chief
2016-11-22 23:51
Accepted by Company Editor-in-Chief
2016-12-02 10:34
Articles in Press
2016-12-02 10:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-01-04 15:46
Publish the Manuscript Online
2017-01-16 10:39
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort
Manuscript Source Invited Manuscript
All Author List Lukasz A Myc, Jonathan G Stine, Rinita Chakrapani, Alexandra Kadl and Curtis K Argo
Funding Agency and Grant Number
Corresponding Author Curtis K Argo, MD, MS, Division of Gastroenterology and Hepatology, University of Virginia, JPA and Lee Street, MSB 2145, PO Box 800708, Charlottesville, VA 22908, United States. cka3d@virginia.edu
Key Words Portal hypertension; Vasopressor; Liver; Intensive care unit; Hepatology
Core Tip Although the management of septic shock has evolved dramatically in recent decades, data regarding optimal vasopressor therapy in critically-ill patients with cirrhosis is less robust and is based largely on con-sensus expert opinion. We found no difference in 7-d or 28-d mortality with vasopressin use when compared to all other vasoactive agents as a second line agent in catecholamine-resistant septic shock. Further large-scale studies are needed to refine current con-sensus standards and provide further support to our findings.
Publish Date 2017-01-16 10:39
Citation Myc LA, Stine JG, Chakrapani R, Kadl A, Argo CK. Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort. World J Hepatol 2017; 9(2): 106-113
URL http://www.wjgnet.com/1948-5182/full/v9/i2/106.htm
DOI http://dx.doi.org/10.4254/wjh.v9.i2.106
Full Article (PDF) WJH-9-106.pdf
Full Article (Word) WJH-9-106.doc
Manuscript File 28132-Review.docx
Answering Reviewers 28132-Answering reviewers.pdf
Audio Core Tip 28132-Audio core tip.m4a
Biostatistics Review Certificate 28132-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 28132-Conflict-of-interest statement.pdf
Copyright License Agreement 28132-Copyright assignment.pdf
Institutional Review Board Approval Form or Document 28132-Institutional review board statement.pdf
Peer-review Report 28132-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 28132-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 28132-Scientific misconduct check.pdf
Scientific Editor Work List 28132-Scientific editor work list.pdf